🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.8768
-0.0245 (-2.72%)
Nov 18, 2026, 1:12 PM EST - Market open

Spero Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
107.9340.2752.8976.33109.11112.58
Short-Term Investments
-----33.82
Cash & Short-Term Investments
107.9340.2752.8976.33109.11146.4
Cash Growth
122.00%-23.87%-30.71%-30.04%-25.47%15.36%
Accounts Receivable
-25.3649.3949.15--
Other Receivables
-0.033.091.551.082.64
Receivables
-25.3952.4850.71.082.64
Prepaid Expenses
-1.631.914.183.388.83
Total Current Assets
107.9367.29107.28131.21113.57157.87
Property, Plant & Equipment
-1.483.114.165.497.56
Long-Term Accounts Receivable
---46.59--
Other Long-Term Assets
2.10.150.150.445.745.64
Total Assets
110.0368.92110.54182.39124.8171.07

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-0.697.311.380.621.1
Accrued Expenses
-5.5817.276.568.5314.35
Current Portion of Leases
-1.961.751.721.691.36
Current Income Taxes Payable
-0.380.170.39--
Current Unearned Revenue
-0.2622.1227.1110.371.86
Other Current Liabilities
--0.46-0.45-
Total Current Liabilities
-8.8749.0737.1521.6518.67
Long-Term Debt
-----48.41
Long-Term Leases
-0.942.553.834.965.97
Long-Term Unearned Revenue
--12.834.4322.178.79
Other Long-Term Liabilities
109.250.09-0.090.10.94
Total Liabilities
109.259.964.4275.548.8782.78

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.780.060.060.050.050.03
Additional Paid-In Capital
-510.03505.71497.91489.76455.72
Retained Earnings
--451.07-459.64-391.07-413.88-367.46
Comprehensive Income & Other
------0
Total Common Equity
0.7859.0246.12106.8975.9388.29
Shareholders' Equity
0.7859.0246.12106.8975.9388.29
Total Liabilities & Equity
110.0368.92110.54182.39124.8171.07

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-2.94.35.546.6555.75
Net Cash (Debt)
107.9337.3748.5970.79102.4690.65
Net Cash Growth
138.44%-23.09%-31.36%-30.91%13.02%-23.86%
Net Cash Per Share
1.880.630.901.342.732.93
Filing Date Shares Outstanding
58.2357.8955.953.8752.5732.76
Total Common Shares Outstanding
58.2356.4154.595352.4632.39
Working Capital
107.9358.4258.294.0691.92139.2
Book Value Per Share
0.011.050.842.021.452.73
Tangible Book Value
0.7859.0246.12106.8975.9388.29
Tangible Book Value Per Share
0.011.050.842.021.452.73
Machinery
---1.551.551.76
Leasehold Improvements
---1.641.641.64
SEC Filings: 10-K · 10-Q